These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25065896)

  • 1. Molecular imaging in the management of gynecologic malignancies.
    Lai CH; Lin G; Yen TC; Liu FY
    Gynecol Oncol; 2014 Oct; 135(1):156-62. PubMed ID: 25065896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of PET in gynecologic malignancy.
    Grigsby PW
    Curr Opin Oncol; 2009 Sep; 21(5):420-4. PubMed ID: 19553814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of PET-CT pelvic pitfalls in patients with gynecologic malignancies.
    Gorospe L; Jover-Díaz R; Vicente-Bártulos A
    Abdom Imaging; 2012 Dec; 37(6):1041-65. PubMed ID: 22349805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emerging Role of PET/MR Imaging in Gynecologic Cancers.
    Ponisio MR; Fowler KJ; Dehdashti F
    PET Clin; 2016 Oct; 11(4):425-40. PubMed ID: 27593247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/MRI Evaluation of Gynecologic Malignancies and Prostate Cancer.
    Bagade S; Fowler KJ; Schwarz JK; Grigsby PW; Dehdashti F
    Semin Nucl Med; 2015 Jul; 45(4):293-303. PubMed ID: 26050657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
    Chavdarova LI; Tzonevska AD; Piperkova EN
    Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
    Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
    Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT in gynecologic cancer: present applications and future prospects--a clinician's perspective.
    Amit A; Schink J; Reiss A; Lowenstein L
    Obstet Gynecol Clin North Am; 2011 Mar; 38(1):1-21, vii. PubMed ID: 21419325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Molecular Imaging Techniques in Gynecologic Oncology.
    Lin G; Lai CH; Yen TC
    PET Clin; 2018 Apr; 13(2):289-299. PubMed ID: 29482755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/MRI in Gynecologic Malignancy.
    Larson M; Lovrec P; Sadowski EA; Pirasteh A
    Radiol Clin North Am; 2023 Jul; 61(4):713-723. PubMed ID: 37169433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron Emission Tomography/Computed Tomography for Gynecologic Malignancies.
    Oldan JD; Patel PS
    Obstet Gynecol Surv; 2016 Sep; 71(9):545-56. PubMed ID: 27640609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of gynecologic cancer with MR imaging, 18F-FDG PET/CT, and PET/MR imaging.
    Lee SI; Catalano OA; Dehdashti F
    J Nucl Med; 2015 Mar; 56(3):436-43. PubMed ID: 25635136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
    Treglia G; Annunziata S; Sobic-Saranovic D; Bertagna F; Caldarella C; Giovanella L
    Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography application for gynecologic tumors.
    Nakamoto Y; Saga T; Fujii S
    Int J Gynecol Cancer; 2005; 15(5):701-9. PubMed ID: 16174216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What's New in Imaging for Gynecologic Cancer?
    Khan SR; Arshad M; Wallitt K; Stewart V; Bharwani N; Barwick TD
    Curr Oncol Rep; 2017 Nov; 19(12):85. PubMed ID: 29105030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/MR Imaging in Gynecologic Oncology.
    Ohliger MA; Hope TA; Chapman JS; Chen LM; Behr SC; Poder L
    Magn Reson Imaging Clin N Am; 2017 Aug; 25(3):667-684. PubMed ID: 28668166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Present and future role of FDG-PET/CT imaging in the management of gynecologic malignancies.
    Kitajima K; Ebina Y; Sugimura K
    Jpn J Radiol; 2014 Jun; 32(6):313-23. PubMed ID: 24744135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
    Qu X; Huang X; Yan W; Wu L; Dai K
    Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.